Wian de Jongh | CEO
adaptvac

Dr. de Jongh has a M.Sc. in Chemical Engineering from the University of Stellenbosch, South Africa and was awarded a doctorate in Biotechnology from the Technical University of Denmark (DTU). Furthermore, he was awarded an affiliated associate professorship at DTU in 2017. Dr. de Jongh has 18years experience in the Biopharmaceutical industry, including 10 years as CSO and co-founder of NASDAQ First North listed ExpreS2ion Biotechnologies, and as CEO and co-founder of AdaptVac since 2017.